VYNE Therapeutics Inc (VYNE) stock will jump on 15 May and go up on 16 May according to our mathematic model.
Related News:
VYNE Therapeutics Inc. Reports Results for the First Quarter Ended March 31, 2023
VYNE Therapeutics Inc. reported results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue of $0.099 million, compared to $0.178 million a year ago. The net loss amounted to 5.62 million USD, compared to a net profit of 4.67 million USD a year ago.
Basic loss per share from continuing operations was $1.74, compared to $2.83 a year ago. Diluted loss per share from continuing operations was $1.74, compared to $2.83 a year ago. Basic loss per share was $1.74, compared to basic earnings per share of $1.51 a year ago.
Diluted loss per share was $1.74 compared to diluted earnings per share of $1.51 a year ago.